Structured Summary
Abstract
Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase.
MeSH Record
Classification
Broader headings
Narrower headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
1 entry terms
- Thromboxane
MeSH Record
Aspects Covered
28 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
78
MeSH Record
Previous Indexing
- Fatty Acids, Unsaturated (1973-1974)
- Hydroxy Acids (1975-1977)
- Pyrans (1966-1977)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Thromboxanes. Medical Subject Headings (MeSH). 2026. Unique ID D013931. http://id.nlm.nih.gov/mesh/2026/D013931
- Thromboxanes. In: Wikipedia. https://en.wikipedia.org/wiki/Thromboxane
- Thromboxanes. In: Wikidata. https://www.wikidata.org/wiki/Q412212